Previous GWAS and candidate gene studies have improved the genetic understanding of MASLD, such as the I148M PNPLA3 variant or variants in TM6SF2, MBOAT7, and GCKR.33 The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.